1. Home
  2. PCG vs GEHC Comparison

PCG vs GEHC Comparison

Compare PCG & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacific Gas & Electric Co.

PCG

Pacific Gas & Electric Co.

HOLD

Current Price

$18.20

Market Cap

34.3B

Sector

Utilities

ML Signal

HOLD

Logo GE HealthCare Technologies Inc.

GEHC

GE HealthCare Technologies Inc.

HOLD

Current Price

$70.44

Market Cap

35.8B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCG
GEHC
Founded
1995
1892
Country
United States
United States
Employees
N/A
N/A
Industry
Power Generation
Computer Software: Prepackaged Software
Sector
Utilities
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
34.3B
35.8B
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
PCG
GEHC
Price
$18.20
$70.44
Analyst Decision
Buy
Buy
Analyst Count
9
12
Target Price
$21.83
$90.83
AVG Volume (30 Days)
18.2M
2.8M
Earning Date
04-23-2026
04-29-2026
Dividend Yield
1.10%
0.20%
EPS Growth
N/A
4.84
EPS
N/A
4.55
Revenue
N/A
$20,625,000,000.00
Revenue This Year
$7.12
$7.06
Revenue Next Year
$3.46
$4.50
P/E Ratio
$15.15
$15.47
Revenue Growth
N/A
4.84
52 Week Low
$12.97
$57.65
52 Week High
$19.16
$89.77

Technical Indicators

Market Signals
Indicator
PCG
GEHC
Relative Strength Index (RSI) 55.59 31.78
Support Level $14.52 $69.76
Resistance Level $19.16 $74.29
Average True Range (ATR) 0.36 2.01
MACD -0.13 -0.63
Stochastic Oscillator 22.45 10.41

Price Performance

Historical Comparison
PCG
GEHC

About PCG Pacific Gas & Electric Co.

PG&E is a holding company whose main subsidiary is Pacific Gas and Electric, a regulated utility operating in Central and Northern California that serves 5.3 million electricity customers and 4.6 million gas customers in 47 of the state's 58 counties. PG&E operated under bankruptcy court supervision between January 2019 and June 2020. In 2004, PG&E sold its unregulated assets as part of an earlier postbankruptcy reorganization.

About GEHC GE HealthCare Technologies Inc.

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).

Share on Social Networks: